| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adrenomedullin: A new modulator of vascular tone
|
Kangawa, Kenji
|
|
1996
|
|
S1 |
p. S135-S140
6 p.
|
artikel
|
| 2 |
A genetic based model of cardiac hypertrophy inMLC-Ras mice
|
Gottshall, Kim R.
|
|
1996
|
|
S1 |
p. S29-S33
5 p.
|
artikel
|
| 3 |
Altered signal transduction system in hypertrophiedmyocardium: Angiotensin II stimulates collagen synthesis in hypertrophied hearts
|
Kawaguchi, Hideaki
|
|
1996
|
|
S1 |
p. S13-S19
7 p.
|
artikel
|
| 4 |
Author index: Volume 2, number 4 supplement, 1996
|
|
|
1996
|
|
S1 |
p. S295-S296
2 p.
|
artikel
|
| 5 |
Baseline Characteristics of Patients in SEQUOIA-HCM: A Phase 3 Trial of Aficamten in Obstructive Hypertrophic Cardiomyopathy
|
Maron, Martin S.
|
|
|
|
S1 |
p. S3
|
artikel
|
| 6 |
Beta-blocker therapy in heart failure: Myths or realities
|
Kelly, David T.
|
|
1996
|
|
S1 |
p. S239-S242
4 p.
|
artikel
|
| 7 |
Calcium antagonists in patients with left ventriculardysfunction: back on the bridge?
|
Lewis, Basil S.
|
|
1996
|
|
S1 |
p. S259-S265
7 p.
|
artikel
|
| 8 |
Calcium channel blockers in heart failure: Help or hindrance?
|
Konstam, Marvin A.
|
|
1996
|
|
S1 |
p. S251-S257
7 p.
|
artikel
|
| 9 |
Changes in beta-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure
|
Flesch, Markus
|
|
1996
|
|
S1 |
p. S35-S43
9 p.
|
artikel
|
| 10 |
Changes of myocardial contractile state and theintracellular calcium transients during transitions to heart failure: Studies in dahl rat heart failure model
|
Kihara, Yasuki
|
|
1996
|
|
S1 |
p. S113-S120
8 p.
|
artikel
|
| 11 |
Classifying pathogenicity of TPM1 variants of unknown significance using in vitro and in silico approaches
|
Campbell, Stuart
|
|
|
|
S1 |
p. S3
|
artikel
|
| 12 |
Clinical manifestations of hypertrophiccardiomyopathy with mutations in the cardiac beta-myosin heavy chain gene or cardiac troponin T gene
|
Koga, Yoshinori
|
|
1996
|
|
S1 |
p. S97-S103
7 p.
|
artikel
|
| 13 |
Cumulative long-term efficacy and safety of mavacamten treatment in nonobstructive hypertrophic cardiomyopathy: updated interim analysis from the MAVERICK cohort of the MAVA-long-term extension (LTE) study up to 120 weeks
|
Owens, Anjali
|
|
|
|
S1 |
p. S2-S3
|
artikel
|
| 14 |
Deficient cellular cyclic AMP may causeboth cardiac and skeletal muscle dysfunction in heart failure
|
Grossman, Jessica D.
|
|
1996
|
|
S1 |
p. S105-S111
7 p.
|
artikel
|
| 15 |
Design of DISCOVER-HCM: A Registry of Real-world Treatment Patterns and Outcomes of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy
|
Hernandez, Adrian
|
|
|
|
S1 |
p. S4
|
artikel
|
| 16 |
Effects of endothelin-1 on [Ca2+]i-shorteningtrajectory and Ca2+ sensitivity in rabbit single ventricular cardiomyocytes loaded with Indo-1/AM: Comparison with the effects of phenylephrine and angiotensin II
|
Fujita, Shinji
|
|
1996
|
|
S1 |
p. S45-S57
13 p.
|
artikel
|
| 17 |
Endocardial endothelial dysfunctionand heart failure
|
Andries, Luc J.
|
|
1996
|
|
S1 |
p. S195-S202
8 p.
|
artikel
|
| 18 |
Endothelial nitric oxide pathway function in the peripheral vasculature of patients with heart failure
|
Kubo, Spencer H.
|
|
1996
|
|
S1 |
p. S217-S223
7 p.
|
artikel
|
| 19 |
Endothelin-1 regulates normal cardiovascular development and cardiac cellular hypertrophy
|
Yamazaki, Tsutomu
|
|
1996
|
|
S1 |
p. S7-S12
6 p.
|
artikel
|
| 20 |
Endothelium and platelet activity in heart failure
|
Bassenge, Eberhard
|
|
1996
|
|
S1 |
p. S203-S208
6 p.
|
artikel
|
| 21 |
Gene expression of the Na-Ca exchangerin cardiac hypertrophy
|
Menick, Donald R.
|
|
1996
|
|
S1 |
p. S69-S76
8 p.
|
artikel
|
| 22 |
Immunomodulation: A new horizon for medicaltreatment of heart failure
|
Sasayama, Shigetake
|
|
1996
|
|
S1 |
p. S287-S294
8 p.
|
artikel
|
| 23 |
Immunopathogenesis and treatment of myocarditis: The United States myocarditis treatment trial
|
Mason, Jay W.
|
|
1996
|
|
S1 |
p. S173-S177
5 p.
|
artikel
|
| 24 |
Impact of a Center of Excellence in Confirming or Excluding a Diagnosis of Hypertrophic Cardiomyopathy
|
Farrar, Elizabeth
|
|
|
|
S1 |
p. S4
|
artikel
|
| 25 |
Ion channel blockers in the treatment of Chronic heart failure
|
Toyama, Junji
|
|
1996
|
|
S1 |
p. S243-S249
7 p.
|
artikel
|
| 26 |
Left Atrial Functional Assessment in Hypertrophic Cardiomyopathy Patients Receiving Mavacamten
|
Muuse, Janelle
|
|
|
|
S1 |
p. S5
|
artikel
|
| 27 |
Low Seroprevalence of Neutralizing Antibodies to Adeno-Associated Virus Serotype 9 (AAV9) in Preparation for MyPeak-1, the First-in-Human Study of TN-201, an Investigational AAV9-Mediated Gene Therapy for Individuals with MYBPC3-Associated Hypertrophic Cardiomyopathy (HCM)
|
Desai, Milind
|
|
|
|
S1 |
p. S5
|
artikel
|
| 28 |
Molecular and functional heterogeneity of inward rectifier potassium channels in brain and heart
|
Kurachi, Yoshihisa
|
|
1996
|
|
S1 |
p. S59-S62
4 p.
|
artikel
|
| 29 |
Molecular basis of the regression of cardiac hypertrophy
|
Swynghedauw, Bernard
|
|
1996
|
|
S1 |
p. S21-S27
7 p.
|
artikel
|
| 30 |
Molecular genetics of hypertrophic cardiomyopathy
|
Roberts, Robert
|
|
1996
|
|
S1 |
p. S87-S95
9 p.
|
artikel
|
| 31 |
MyPeak-1: A Phase 1b Study to Evaluate Safety and Efficacy of TN-201, an Adeno-Associated Virus Serotype 9 (AAV9) Investigational Gene Therapy, in Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy (HCM)
|
Haroldson, Jeff
|
|
|
|
S1 |
p. S5
|
artikel
|
| 32 |
Natriuretic peptides in the treatment of heart failure
|
Yasue, Hirofumi
|
|
1996
|
|
S1 |
p. S277-S285
9 p.
|
artikel
|
| 33 |
Newer aspects of pathogenesis of heart failure:Hepatitis C virus infection in myocarditis and cardiomyopathy
|
Matsumori, Akira
|
|
1996
|
|
S1 |
p. S187-S194
8 p.
|
artikel
|
| 34 |
Outside Front Cover
|
|
|
|
|
S1 |
p. CO1
|
artikel
|
| 35 |
Paracrine coronary endothelial modulation of diastolic left ventricular function in man: Implications for diastolic heart failure
|
Paulus, Walter J.
|
|
1996
|
|
S1 |
p. S155-S164
10 p.
|
artikel
|
| 36 |
Positive inotropic therapy: Dead end ornew horizon?
|
Remme, Willem J.
|
|
1996
|
|
S1 |
p. S267-S276
10 p.
|
artikel
|
| 37 |
Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy
|
Ravi, Srekar
|
|
|
|
S1 |
p. S1-S2
|
artikel
|
| 38 |
Prognosis in congestive heart failure
|
Cohn, Jay N.
|
|
1996
|
|
S1 |
p. S225-S229
5 p.
|
artikel
|
| 39 |
Regulation of nitric oxide synthase gene expressionby cytokines
|
Yokoyama, Mitsuhiro
|
|
1996
|
|
S1 |
p. S179-S185
7 p.
|
artikel
|
| 40 |
Role of endothelium in control of forearm bloodflow in patients with heart failure
|
Takeshita, Akira
|
|
1996
|
|
S1 |
p. S209-S215
7 p.
|
artikel
|
| 41 |
Roles of gp130 signaling pathways in cardiac myocytes: Recent advances and implications for cardiovascular disease
|
Yamauchi-Takihara, Keiko
|
|
1996
|
|
S1 |
p. S63-S67
5 p.
|
artikel
|
| 42 |
Roles of natriuretic peptides in heart failure
|
Nakao, Kazuwa
|
|
1996
|
|
S1 |
p. S129-S133
5 p.
|
artikel
|
| 43 |
SR Ca2+-ATPase/phospholamban incardiomyocyte function
|
Tada, Michihiko
|
|
1996
|
|
S1 |
p. S77-S85
9 p.
|
artikel
|
| 44 |
State of the art on heart failure syndrome
|
Sasayama, Shigetake
|
|
1996
|
|
S1 |
p. v-vi
nvt p.
|
artikel
|
| 45 |
The effect of tumor necrosis factor-alphaon cardiac structure and function: A tale of two cytokines
|
Mann, Douglas L.
|
|
1996
|
|
S1 |
p. S165-S172
8 p.
|
artikel
|
| 46 |
The role of hypertrophy and growth factors inheart failure
|
Ross Jr, John
|
|
1996
|
|
S1 |
p. S121-S128
8 p.
|
artikel
|
| 47 |
The role of the cardiac renin-angiotensin system inload-induced cardiac hypertrophy
|
Sadoshima, Jun-Ichi
|
|
1996
|
|
S1 |
p. S1-S6
6 p.
|
artikel
|
| 48 |
The role of the NO pathway in the control of cardiac function
|
Smith, Thomas W.
|
|
1996
|
|
S1 |
p. S141-S147
7 p.
|
artikel
|
| 49 |
The use of ACE inhibitors aftermyocardial infarction
|
Swedberg, Karl
|
|
1996
|
|
S1 |
p. S231-S237
7 p.
|
artikel
|
| 50 |
Toxic action of nitric oxide on myocardial cells:Direct evidence from gene transfer in vivo
|
Shin, Wee Soo
|
|
1996
|
|
S1 |
p. S149-S153
5 p.
|
artikel
|
Tijdschrift beschrijving